<SEC-DOCUMENT>0000935836-25-000018.txt : 20250103
<SEC-HEADER>0000935836-25-000018.hdr.sgml : 20250103
<ACCEPTANCE-DATETIME>20250103194502
ACCESSION NUMBER:		0000935836-25-000018
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250103
DATE AS OF CHANGE:		20250103

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PROTHENA CORP PUBLIC LTD CO
		CENTRAL INDEX KEY:			0001559053
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L2
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-87112
		FILM NUMBER:		25508668

	BUSINESS ADDRESS:	
		STREET 1:		77 SIR JOHN ROGERSON'S QUAY, BLOCK C
		STREET 2:		GRAND CANAL DOCKLANDS
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 VK60
		BUSINESS PHONE:		011-353-1-236-2500

	MAIL ADDRESS:	
		STREET 1:		77 SIR JOHN ROGERSON'S QUAY, BLOCK C
		STREET 2:		GRAND CANAL DOCKLANDS
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 VK60

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Prothena Corp plc
		DATE OF NAME CHANGE:	20121102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Neotope Corp Ltd
		DATE OF NAME CHANGE:	20120926

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EcoR1 Capital, LLC
		CENTRAL INDEX KEY:			0001587114
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		357 TEHAMA STREET #3
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103
		BUSINESS PHONE:		415-448-6534

	MAIL ADDRESS:	
		STREET 1:		357 TEHAMA STREET #3
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94103
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0000935836-19-000452</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: EcoR1 Capital, LLC -->
          <cik>0001587114</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>4</amendmentNo>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <dateOfEvent>12/31/2024</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001559053</issuerCIK>
        <issuerCUSIP>G72800108</issuerCUSIP>
        <issuerName>Prothena Corporation plc</issuerName>
        <address>
          <com:street1>77 Sir John Rogerson's Quay, Block C, Gr</com:street1>
          <com:city>Dublin</com:city>
          <com:stateOrCountry>L2</com:stateOrCountry>
          <com:zipCode>D02 VK60</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Anthony J. Caldwell, Esq.</personName>
          <personPhoneNum>(415) 421-6500</personPhoneNum>
          <personAddress>
            <com:street1>Shartsis Friese LLP</com:street1>
            <com:street2>425 Market Street, 11th Floor</com:street2>
            <com:city>San Francisco</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>94105</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001587114</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>EcoR1 Capital, LLC</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>11584280.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>11584280.00</sharedDispositivePower>
        <aggregateAmountOwned>11584280.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>21.5</percentOfClass>
        <typeOfReportingPerson>IA</typeOfReportingPerson>
        <typeOfReportingPerson>OO</typeOfReportingPerson>
        <commentContent>Percentage calculated based on 53,808,732 Ordinary Shares outstanding on November 6, 2024, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2024.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001454385</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Oleg Nodelman</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>11584280.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>11584280.00</sharedDispositivePower>
        <aggregateAmountOwned>11584280.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>21.5</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <typeOfReportingPerson>HC</typeOfReportingPerson>
        <commentContent>Percentage calculated based on 53,808,732 Ordinary Shares outstanding on November 6, 2024, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2024.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001598292</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>EcoR1 Capital Fund Qualified, L.P.</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>10847852.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>10847852.00</sharedDispositivePower>
        <aggregateAmountOwned>10847852.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>20.2</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
        <commentContent>Percentage calculated based on 53,808,732 Ordinary Shares outstanding on November 6, 2024, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2024.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Ordinary Shares</securityTitle>
        <issuerName>Prothena Corporation plc</issuerName>
        <issuerPrincipalAddress>
          <com:street1>77 Sir John Rogerson's Quay, Block C, Gr</com:street1>
          <com:city>Dublin</com:city>
          <com:stateOrCountry>L2</com:stateOrCountry>
          <com:zipCode>D02 VK60</com:zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item2>
        <filingPersonName>The reporting persons are:
EcoR1 Capital, LLC, a Delaware limited liability company ("EcoR1")

EcoR1 Capital Fund Qualified, L.P., a Delaware limited partnership ("Qualified Fund")

Oleg Nodelman

Qualified Fund is filing this statement jointly with the other reporting persons, but not as a member of a group, and it expressly disclaims membership in a group.  In addition, the filing of this Schedule 13D on behalf of Qualified Fund should not be construed as an admission that it is, and it disclaims that it is, a beneficial owner, as defined in Rule 13d-3 under the Act, of any securities covered by this Schedule 13D.  Each reporting person also disclaims beneficial ownership of the securities reported herein except to the extent of that person's pecuniary interest therein.</filingPersonName>
        <principalBusinessAddress>357 Tehama Street #3, San Francisco, CA 94103</principalBusinessAddress>
        <principalJob>EcoR1 is an investment adviser to investment funds, including Qualified Fund (collectively, the "Funds").  EcoR1 is the general partner of the Funds.  Mr. Nodelman is the manager and control person of EcoR1.</principalJob>
        <hasBeenConvicted>During the last five years, none of the reporting persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>During the last five years, none of the reporting persons was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</convictionDescription>
        <citizenship>For citizenship of the reporting persons, see Item 6 of each reporting person's cover page.</citizenship>
      </item2>
      <item3>
        <fundsSource>The Funds used their working capital to purchase the Issuer's Ordinary Shares.

The amount of funds used in purchasing the Issuer's Ordinary Shares was $125,156,531.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>The reporting persons filed this Schedule 13D because the Issuer's board of directors appointed Oleg Nodelman to serve as a director of the Issuer.  On December 31, 2024, Mr. Nodelman resigned from the Issuer's board of directors.  The reporting persons acquired Ordinary Shares for investment purposes based on their belief that the Issuer's Ordinary Shares, when purchased, was undervalued and represented an attractive investment opportunity.  The reporting persons will routinely monitor the Issuer regarding a wide variety of factors that affect their investment considerations, including, current and anticipated future trading prices of the Ordinary Shares and other securities, the Issuer's operations, assets, prospects, financial position, and business development, Issuer's management, Issuer-related competitive and strategic matters, general economic, financial market and industry conditions, and other investment considerations. Depending on their evaluation of various factors, the reporting persons may take such actions regarding their holdings of the Issuer's securities as they deem appropriate in light of circumstances existing from time to time. Such actions may include purchasing additional Ordinary Shares in the open market, through privately negotiated transactions with third parties or otherwise,  and selling at any time, in the open market, through privately negotiated transactions with third parties or otherwise, all or part of the Ordinary Shares that they now own or hereafter acquire. The reporting persons also may from time to time enter into or unwind hedging or other derivative transactions with respect to the Ordinary Shares or pledge their interests in the Ordinary Shares to obtain liquidity. In addition, from time to time the reporting persons and their representatives and advisers may communicate with other stockholders, industry participants and other interested parties about the Issuer.

The reporting persons have no present plan or proposal that relates to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D.  However, the reporting persons may recommend action to the Issuer's management, board of directors and stockholders. Any such actions could involve one or more of the events referred to in clauses (a) through (j) of Item 4 of Schedule 13D, including, potentially, one or more mergers, consolidations, sales or acquisitions of assets, changes in control, issuances, purchases, dispositions or pledges of securities or other changes in capitalization.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>Aggregate number of shares beneficially owned by the reporting persons:

EcoR1:  11,584,280

Oleg Nodelman:  11,584,280

Qualified Fund:  10,847,852

Aggregate percentage of the class of Ordinary Shares beneficially owned by the reporting persons:

EcoR1:  21.5%

Oleg Nodelman:  21.5%

Qualified Fund:  20.2%</percentageOfClassSecurities>
        <numberOfShares>Number of shares as to which the each reporting person has:

(i) Sole power to vote or to direct the vote:

EcoR1:  0
Oleg Nodelman:  0
Qualified Fund:  0

(ii) Shared power to vote or to direct the vote:

EcoR1:  11,584,280
Oleg Nodelman:  11,584,280
Qualified Fund:  10,847,852

(iii) Sole power to dispose or to direct the disposition of:

EcoR1:  0
Oleg Nodelman:  0
Qualified Fund:  0

(iv) Shared power to dispose or to direct the disposition of:

EcoR1:  11,584,280
Oleg Nodelman:  11,584,280
Qualified Fund:  10,847,852</numberOfShares>
        <transactionDesc>The reporting persons have not engaged in any transactions in the Issuer's Ordinary Shares in the 60 days preceding the date of this Schedule 13D.</transactionDesc>
        <listOfShareholders>Not applicable.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>EcoR1 is the investment adviser to its clients pursuant to investment management agreements or limited partnership agreements providing to EcoR1 the authority, among other things, to invest the funds of such clients in Ordinary Shares, to vote and dispose of Ordinary Shares and to file this statement on behalf of such clients. Pursuant to such limited partnership agreements, EcoR1 is entitled to allocations based on assets under management and realized and unrealized gains.  Pursuant to such investment management agreements, EcoR1 is entitled to fees based on assets under management and realized and unrealized gains.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Exhibit 99.1 Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G.</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>EcoR1 Capital, LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Oleg Nodelman</signature>
          <title>Manager</title>
          <date>01/03/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Oleg Nodelman</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Oleg Nodelman</signature>
          <title>Reporting person</title>
          <date>01/03/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>EcoR1 Capital Fund Qualified, L.P.</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Oleg Nodelman</signature>
          <title>Manager of the General Partner, EcoR1 Capital, LLC</title>
          <date>01/03/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1 AGREEMENT
<SEQUENCE>2
<FILENAME>prta13da4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">EXHIBIT 99.1</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">AGREEMENT REGARDING JOINT FILING</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">OF STATEMENT ON SCHEDULE 13D OR 13G</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The undersigned agree to file jointly with the Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) any and all statements on Schedule 13D or Schedule 13G or Forms 3, 4 or 5(and any amendments
or supplements thereto) required under section 13(d) and 16(a) of the Securities Exchange Act of 1934, as amended, in connection with
purchases by the undersigned of the securities of any issuer. For that purpose, the undersigned hereby constitute and appoint EcoR1 Capital,
LLC, a Delaware limited liability company, as their true and lawful agent and attorney-in-fact, with full power and authority for and
on behalf of the undersigned to prepare or cause to be prepared, sign, file with the SEC and furnish to any other person all certificates,
instruments, agreements and documents necessary to comply with section 13(d) and section 16(a) of the Securities Exchange Act of 1934,
as amended, in connection with said purchases, and to do and perform every act necessary and proper to be done incident to the exercise
of the foregoing power, as fully as the undersigned might or could do if personally present.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Dated:&#9;January 3, 2025</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 53%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B>ECOR1 CAPITAL, LLC</B><BR>
    <BR>
    <BR>
    By:&#9;<I><U>/s/ Oleg Nodelman&#9;&#9;&#9;</U></I><BR>
    &#9;Oleg Nodelman<BR>
    &#9;Manager</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B>ECOR1 CAPITAL FUND QUALIFIED, L.P.<BR>
    <BR>
    </B>By:&#9;EcoR1 Capital, LLC,<BR>
    &#9;General Partner<BR>
    <BR>
    By:&#9;<I><U>/s/ Oleg Nodelman&#9;&#9;&#9;</U></I><BR>
    &#9;Oleg Nodelman<BR>
    &#9;Manager</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><I><U>/s/ Oleg Nodelman&#9;&#9;&#9;</U></I></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Oleg Nodelman</P></TD></TR>
  </TABLE>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
